Trump plans to fire FDA 局长 Robert Mudei

Summary

President Trump plans to fire FDA Commissioner Marty Makary due to frustrations over the agency’s slow pace in approving flavored e-cigarettes and nicotine products [Zhitong]. Reports indicate Trump criticized Makary’s performance in multiple calls and meetings, signaling a desire for a leadership change that will accelerate product approvals [].

Impact Analysis

So Trump is basically moving to clear the ‘regulatory bottleneck’ at the FDA, and Marty Makary is the casualty. The signal here is crystal clear: this isn’t about general performance; it’s specifically about the slow-walking of flavored e-cigarettes and nicotine product approvals []. Trump has been fuming over the FDA’s pace, and firing the Commissioner is his way of demanding an immediate policy pivot toward deregulation [].

For the portfolio, this is a massive green light for the tobacco and vaping sector. By removing a head who likely stuck to restrictive 2020-era guidelines [], Trump is signaling that the next appointee will be an industry hawk focused on ‘speed to market’ rather than traditional regulatory caution. We’ve seen this playbook before—he uses the threat of termination to force compliance with his agenda [etnet]. Bottom line: stay long the big nicotine players. The administrative barrier is about to crumble, and we should expect a flood of product approvals once a more ‘aligned’ successor is installed.